Skip to main content

Together we are beating cancer

Donate now

Children and young people's cancers

Children develop different types of cancers than adults, with around 1,900 children under the age of 14 diagnosed each year. The most common types of childhood cancer are acute leukaemia and cancers of the brain and spinal cord. Thanks to research into new treatments, 8 in 10 children diagnosed with cancer will live for at least five years.
Showing 12 out of 194 results
That Cancer Conversation in a white speech bubble with a dark blue background

In our new podcast series, That Cancer Conversation: One to One, we’re talking to Dr Laura Danielson, our research lead for children’s and young people’s cancer. In our new podcast series, That Cancer Conversation: One to One, we’re talking to Dr Laura Danielson, our research lead for children’s and young people’s cancer.

by Cancer Research UK | Podcast | 1 September 2023

1 September 2023

This entry is part 10 of 15 in the series That Cancer Conversation

Concluding our first Teenager and Young Adult Cancer Awareness Month, we look at how longer waiting times are impacting their mental health. Concluding our first Teenager and Young Adult Cancer Awareness Month, we look at how longer waiting times are impacting their mental health.

by Sophie Wedekind | Analysis | 27 April 2023

27 April 2023

Lab equipment at our Experimental Cancer Medicine Centre in Southampton
  • Science & Technology
  • Health & Medicine

3 ways we're helping teenagers and young adults with cancer

Teenagers and young adults with cancer have to deal with unique challenges. We're using our expertise to help tackle them. Teenagers and young adults with cancer have to deal with unique challenges. We're using our expertise to help tackle them.

by Tim Gunn | In depth | 18 April 2023

18 April 2023

Fatimah, 19, near her home, and Adam, 23, on holiday. They were both diagnosed with cancer in their mid-teens.

For Teenage and Young Adult Cancer Awareness Month, we're hearing from four supporters who've faced the unique challenges of teenage cancer. For Teenage and Young Adult Cancer Awareness Month, we're hearing from four supporters who've faced the unique challenges of teenage cancer.

by Tom Bourton | Personal stories | 6 April 2023

6 April 2023

A scientist handling patient samples at an experimental cancer medicine centre.

We're helping treble funding for paediatric Experimental Cancer Medicine Centres, paving the way to more effective and less toxic treatments for children and young people. We're helping treble funding for paediatric Experimental Cancer Medicine Centres, paving the way to more effective and less toxic treatments for children and young people.

by Tim Gunn | In depth | 3 April 2023

3 April 2023

A Cancer Grand Challenges graphic announcing 9 new challenges
  • Science & Technology
  • Health & Medicine

Time to take on 9 new Cancer Grand Challenges

These are some of the biggest questions in cancer research. Cancer Grand Challenges are looking for research teams that can help answer them. These are some of the biggest questions in cancer research. Cancer Grand Challenges are looking for research teams that can help answer them.

by Tim Gunn | News | 8 March 2023

8 March 2023

Professor Carolyn Bertozzi with graduate student Mireille Kamariza

Professor Carolyn Bertozzi won the 2022 Nobel Prize in Chemistry. She's using all she's learned to create better treatments for solid tumours in children. Professor Carolyn Bertozzi won the 2022 Nobel Prize in Chemistry. She's using all she's learned to create better treatments for solid tumours in children.

by Tim Gunn | Analysis | 8 November 2022

8 November 2022

Tissue stain of medulloblastoma - which is densely cellular and discrete from other tissue

Our scientists have found tiny cellular changes that make medulloblastomas resistant to treatment. Understanding them could help us treat the disease in future. Our scientists have found tiny cellular changes that make medulloblastomas resistant to treatment. Understanding them could help us treat the disease in future.

by Lilly Matson | Analysis | 4 November 2022

4 November 2022

A newly merged biobank will be UK’s leading biomedical research resource dedicated to storing samples and data of cancers in children and young people - we explore its potential impact... A newly merged biobank will be UK’s leading biomedical research resource dedicated to storing samples and data of cancers in children and young people - we explore its potential impact...

by Phil Prime | Interview | 27 September 2022

27 September 2022

A photograph of someone holding a test tube in a lab.

We spoke to Dr Debbie Hicks about what is being done to understand and minimise the impact of long-term side effects for children and young people with medulloblastoma. We spoke to Dr Debbie Hicks about what is being done to understand and minimise the impact of long-term side effects for children and young people with medulloblastoma.

by Lilly Matson | Analysis | 22 September 2022

22 September 2022

An electron microscope image of white blood cells

In 1930, it was discovered that children with Down syndrome are at a greater risk of developing certain types of leukaemia, but much of our understanding of this link remains a mystery. In 1930, it was discovered that children with Down syndrome are at a greater risk of developing certain types of leukaemia, but much of our understanding of this link remains a mystery.

by Lilly Matson | Analysis, Personal stories | 1 September 2022

1 September 2022

Cancer Research UK researchers

Today, Cancer Grand Challenges announced four new teams that have each received £20 million in funding to take on the biggest challenges in cancer research Today, Cancer Grand Challenges announced four new teams that have each received £20 million in funding to take on the biggest challenges in cancer research

by Jacob Smith | Analysis | 16 June 2022

16 June 2022

This entry is part 1 of 2 in the series Inside Cancer Grand Challenges